|
KIAA0196 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.55059997964236E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.74969999892028E-08 |
| Normal-vs-Stage2 |
7.82320000000114E-05 |
| Normal-vs-Stage3 |
8.07659999990662E-08 |
| Normal-vs-Stage4 |
2.52869999994854E-06 |
| Stage1-vs-Stage2 |
9.759400E-01 |
| Stage1-vs-Stage3 |
3.459200E-01 |
| Stage1-vs-Stage4 |
5.425200E-01 |
| Stage2-vs-Stage3 |
5.547200E-01 |
| Stage2-vs-Stage4 |
6.607800E-01 |
| Stage3-vs-Stage4 |
9.204200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.51469997550424E-09 |
| Normal-vs-AfricanAmerican |
1.060080E-03 |
| Normal-vs-Asian |
1.983430E-04 |
| Caucasian-vs-AfricanAmerican |
5.242400E-01 |
| Caucasian-vs-Asian |
5.118800E-01 |
| AfricanAmerican-vs-Asian |
9.074000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.99560001856725E-09 |
| Normal-vs-Female |
8.17309999678884E-08 |
| Male-vs-Female |
3.929900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.01980000000168E-06 |
| Normal-vs-Age(41-60Yrs) |
3.41340000709067E-09 |
| Normal-vs-Age(61-80Yrs) |
2.09250000005046E-06 |
| Normal-vs-Age(81-100Yrs) |
3.420000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.602600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.649600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.166400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.475600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.842200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.121600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.130800E-01 |
| Classical-VS-Follicular |
3.535800E-01 |
| Classical-VS-Other |
6.356500E-02 |
| Classical-VS-Normal |
3.76590000294996E-08 |
| Tall-VS-Follicular |
5.345000E-01 |
| Tall-VS-Other |
9.304400E-02 |
| Tall-VS-Normal |
8.382600E-04 |
| Follicular-VS-Other |
2.648200E-01 |
| Follicular-VS-Normal |
1.51941999999572E-05 |
| Other-VS-Normal |
3.952200E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.55700000062475E-08 |
| Normal-vs-N1 |
5.4838000029811E-08 |
| N0-vs-N1 |
1.367410E-01 |
|
|
